Bioscompass acquires ADCON Anti-Adhesion Gel for dura and and tendons with the goal getting US clearance

Bioscompass Acquires Anti-Adhesion Gel (Orthopedics This Week) Rochester, Minnesota-based BiosCompass, Inc. has acquired the IP (intellectual property) for Adcon Gel from AaP Implanate AG and EMCM B.V. The product is a biocompatible, resorbable gel that provides a physical barrier to inter-tissue adhesions by inhibiting fibroblast migration onto and around neural or tendinous structures. According to the company, the design of the gel is based on the concept of establishing a temporary basal lamina by combining an absorbable, collagen-derived material with a resorbable polyglycan ester. A majo...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top